Preclinical studies supports US Army’s pan-coronavirus vaccine development strategy \
4 min read
\
\

Preclinical studies supports US Army’s pan-coronavirus vaccine development strategy

22-Dec-2021
Washington [US], December 22 (ANI): The Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine developed by researchers at the Walter Reed Army Institute of Research (WRAIR) not only elicits a potent immune response but may also provide broad protection against SARS-CoV-2 variants of concern as well as other coronaviruses, according to a series of recently published preclinical study.
22-Dec-2021 World
\